Cargando…

The Molecular Prevalence of Viral Infections in Transplant Candidates with Bone Marrow Suppression, Shiraz, Southern Iran, 2010

Background: Transient bone marrow suppression, characterized by acute inability of the bone marrow to produce circulating blood cells, may strongly relate to the pathogenesis of some viral infections. Objective: To study the prevalence of some DNA and RNA viruses in patients with transient bone marr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammadi, B., Yaghobi, R., Dehghani, M., Behzad Behbahani, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Organ Transplantation Institute 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089309/
https://www.ncbi.nlm.nih.gov/pubmed/25013658
_version_ 1782325107897663488
author Mohammadi, B.
Yaghobi, R.
Dehghani, M.
Behzad Behbahani, A.
author_facet Mohammadi, B.
Yaghobi, R.
Dehghani, M.
Behzad Behbahani, A.
author_sort Mohammadi, B.
collection PubMed
description Background: Transient bone marrow suppression, characterized by acute inability of the bone marrow to produce circulating blood cells, may strongly relate to the pathogenesis of some viral infections. Objective: To study the prevalence of some DNA and RNA viruses in patients with transient bone marrow suppression. Methods: EDTA-treated blood samples were collected from 27 patients with clinically- and laboratory-confirmed transient bone marrow suppression. The genomic DNA of hepatitis B virus, adenovirus, polyomavirus BK, and parvovirus B19, and genomic RNA of hepatitis C and G viruses were extracted and amplified by sensitive and specific in-house simple and nested PCR and RT-PCR protocols, respectively. The risk factors that might be related to the studied viral infections were analyzed. Results: Hepatitis B virus infection was diagnosed in 9 (33%) of 27 patients; adenovirus infection in 2 (7%); and parvovirus B19 infection in 7 (26%) of 27 patients. The genomic DNA of polyomovirus BK was not detected in any patients. Both hepatitis C and G viruses were found in 3 (11%) of 27 patients. Conclusion: Diagnosis of the high prevalence of hepatitis B virus, and parvovirus B19 in patients with transient bone marrow suppression, reflects the importance of these viral infections in introducing bone marrow suppression. This hypothesis should be confirmed in further studies.
format Online
Article
Text
id pubmed-4089309
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Avicenna Organ Transplantation Institute
record_format MEDLINE/PubMed
spelling pubmed-40893092014-07-10 The Molecular Prevalence of Viral Infections in Transplant Candidates with Bone Marrow Suppression, Shiraz, Southern Iran, 2010 Mohammadi, B. Yaghobi, R. Dehghani, M. Behzad Behbahani, A. Int J Organ Transplant Med Original Article Background: Transient bone marrow suppression, characterized by acute inability of the bone marrow to produce circulating blood cells, may strongly relate to the pathogenesis of some viral infections. Objective: To study the prevalence of some DNA and RNA viruses in patients with transient bone marrow suppression. Methods: EDTA-treated blood samples were collected from 27 patients with clinically- and laboratory-confirmed transient bone marrow suppression. The genomic DNA of hepatitis B virus, adenovirus, polyomavirus BK, and parvovirus B19, and genomic RNA of hepatitis C and G viruses were extracted and amplified by sensitive and specific in-house simple and nested PCR and RT-PCR protocols, respectively. The risk factors that might be related to the studied viral infections were analyzed. Results: Hepatitis B virus infection was diagnosed in 9 (33%) of 27 patients; adenovirus infection in 2 (7%); and parvovirus B19 infection in 7 (26%) of 27 patients. The genomic DNA of polyomovirus BK was not detected in any patients. Both hepatitis C and G viruses were found in 3 (11%) of 27 patients. Conclusion: Diagnosis of the high prevalence of hepatitis B virus, and parvovirus B19 in patients with transient bone marrow suppression, reflects the importance of these viral infections in introducing bone marrow suppression. This hypothesis should be confirmed in further studies. Avicenna Organ Transplantation Institute 2013 2013-05-01 /pmc/articles/PMC4089309/ /pubmed/25013658 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Mohammadi, B.
Yaghobi, R.
Dehghani, M.
Behzad Behbahani, A.
The Molecular Prevalence of Viral Infections in Transplant Candidates with Bone Marrow Suppression, Shiraz, Southern Iran, 2010
title The Molecular Prevalence of Viral Infections in Transplant Candidates with Bone Marrow Suppression, Shiraz, Southern Iran, 2010
title_full The Molecular Prevalence of Viral Infections in Transplant Candidates with Bone Marrow Suppression, Shiraz, Southern Iran, 2010
title_fullStr The Molecular Prevalence of Viral Infections in Transplant Candidates with Bone Marrow Suppression, Shiraz, Southern Iran, 2010
title_full_unstemmed The Molecular Prevalence of Viral Infections in Transplant Candidates with Bone Marrow Suppression, Shiraz, Southern Iran, 2010
title_short The Molecular Prevalence of Viral Infections in Transplant Candidates with Bone Marrow Suppression, Shiraz, Southern Iran, 2010
title_sort molecular prevalence of viral infections in transplant candidates with bone marrow suppression, shiraz, southern iran, 2010
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089309/
https://www.ncbi.nlm.nih.gov/pubmed/25013658
work_keys_str_mv AT mohammadib themolecularprevalenceofviralinfectionsintransplantcandidateswithbonemarrowsuppressionshirazsoutherniran2010
AT yaghobir themolecularprevalenceofviralinfectionsintransplantcandidateswithbonemarrowsuppressionshirazsoutherniran2010
AT dehghanim themolecularprevalenceofviralinfectionsintransplantcandidateswithbonemarrowsuppressionshirazsoutherniran2010
AT behzadbehbahania themolecularprevalenceofviralinfectionsintransplantcandidateswithbonemarrowsuppressionshirazsoutherniran2010
AT mohammadib molecularprevalenceofviralinfectionsintransplantcandidateswithbonemarrowsuppressionshirazsoutherniran2010
AT yaghobir molecularprevalenceofviralinfectionsintransplantcandidateswithbonemarrowsuppressionshirazsoutherniran2010
AT dehghanim molecularprevalenceofviralinfectionsintransplantcandidateswithbonemarrowsuppressionshirazsoutherniran2010
AT behzadbehbahania molecularprevalenceofviralinfectionsintransplantcandidateswithbonemarrowsuppressionshirazsoutherniran2010